Clinical Trial

Topical GHK-Cu Gel for Acute Skin Wound Healing

Study acronym: CuHeal
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study will evaluate whether a topical gel containing GHK-Cu (a copper(II)-peptide complex) can safely speed up healing of small, standardized skin wounds in healthy adults compared with a matching vehicle gel. Participants will receive two small punch-biopsy wounds on the upper arm; each wound will be randomly assigned to receive GHK-Cu gel or vehicle gel under identical dressings. Wounds will be photographed and assessed over 3 weeks, with a follow-up visit to evaluate scar quality.
Trial Details
NCT Number NCT07437586
Lead Sponsor Hudson Biotech
Conditions Acute Standardized Cutaneous Wounds (Punch-biopsy Wounds)
Enrollment 60 participants
Start Date 2026-02-02
Primary Completion 2027-02-14 (estimated)
Study Completion 2028-03-17 (estimated)
Updated on ClinicalTrials.gov 2026-02-27